Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/82615
Título
Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors
Autor
Año del Documento
2012
Editorial
Elservier
Descripción
Producción Científica
Documento Fuente
Tamayo, E., Gómez, E., Bustamante, J., Gómez-Herreras, J. I., Fonteriz, R., Bobillo, F., Bermejo-Martín, J. F., Castrodeza, J., Heredia, M., Fierro, I., & Álvarez, F. J. (2012). Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors. Journal of critical care, 27(4), . https://doi.org/10.1016/j.jcrc.2011.09.001
Zusammenfassung
Purpose: The aims were to analyze the temporal evolution of neutrophil apoptosis, to determine the differences in neutrophil apoptosis among 28-day survivors and nonsurvivors, and to evaluate the use of neutrophil apoptosis as a predictor of mortality in patients with septic shock.
Materials and methods: Prospective multicenter observational study carried out between July 2006 and June 2009. The staining solution study included 80 patients with septic shock and 25 healthy volunteers. Neutrophil apoptosis was assessed by fluorescein isothiocyanate (FITC)-conjugated annexin V and aminoactinomycin D staining.
Results: The percentage of neutrophil apoptosis was significantly decreased at 24 hours, 5 days, and 12 days after the diagnosis of septic shock (14.8% ± 13.4%, 13.4% ± 8.4%, and 15.4% ± 12.8%, respectively; P < .0001) compared with the control group (37.6% ± 12.8%). The difference in apoptosis between 28-day surviving and nonsurviving patients was nonsignificant (P > .05). The mortality rate at 28 days was 53.7%. The crude hazard ratio for mortality in patients with septic shock did not differ according to the percentage of apoptosis (hazard ratio, 1.006; 95% confidence interval, 0.98-1.03; P = .60).
Conclusions: During the first 12 days of septic shock development, the level of neutrophil apoptosis decreases and does not recover normal values. No differences were observed between surviving and nonsurviving patients.
ISSN
0883-9441
Revisión por pares
SI
Patrocinador
This work was supported in part by a grant from the “Gerencia de Salud, Consejería de Sanidad, Junta de Castilla y Leon” (GRS 143/ A/07) and Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional FEDER, Red de Trastornos Adictivos RD06/0001/0020.
Idioma
eng
Tipo de versión
info:eu-repo/semantics/publishedVersion
Derechos
openAccess
Aparece en las colecciones
Dateien zu dieser Ressource
Tamaño:
527.4Kb
Formato:
Adobe PDF
Descripción:
Main article








